Sou Hu Cai Jing·2025-09-07 17:15Core Viewpoint - Shenzhen Huatai Medical (688617) has seen a recent increase in shareholding by its controlling shareholder, Shenzhen Mindray Technology Holdings Co., Ltd. (Mindray), which has raised its stake to 25.00% through a block trade [3][4][5]. Trading Information Summary - As of September 5, 2025, Huatai Medical's stock closed at 309.44 CNY, up 1.82%, with a turnover rate of 1.25%, trading volume of 17,600 lots, and a transaction value of 548 million CNY [1]. - On the same day, the net inflow of main funds was 64.10 million CNY, while retail and speculative funds saw net outflows of 2.29 million CNY and 61.81 million CNY, respectively [2][6]. Company Announcement Summary - Mindray increased its holdings in Huatai Medical by 655,536 shares, representing 0.46% of the total share capital, at a price of 248.20 CNY per share. Following this transaction, Mindray and its concerted party, Zhuhai Tongsheng Investment Partnership, hold a combined total of 35,253,449 shares, or 25.00% of the total share capital [3][4][5]. - The funding for this acquisition came from Mindray's own or self-raised funds, and it does not involve any funds from the company or its related parties [4][5]. Detailed Equity Change Report - The detailed equity change report indicates that the total transaction value for the shares acquired by Mindray was approximately 162.70 million CNY [5]. - The report confirms that this equity change does not lead to any change in the controlling shareholder or actual controller of the company, maintaining the company's independence and avoiding any adverse effects on related transactions [3][4][5].